Clinical trial
A Prospective Audit of Perioperative Parameters of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)
NCT02754115 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Audit of Perioperative Parameters of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)
- Lead sponsor
- Tata Memorial Centre
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 30, 2016
- Completion date
- January 31, 2027
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer, ovarian cancer, peritoneal disease